razoxane has been researched along with merbarone in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allan, WP; Fattman, CL; Hasinoff, BB; Yalowich, JC | 1 |
Anderson, H; Roberge, M | 1 |
Allan, WP; Creighton, AM; Fattman, CL; Hasinoff, BB; Kuschak, TI; Thampatty, P; Yalowich, JC | 1 |
Beck, WT; Mo, YY | 1 |
Falck, J; Jensen, LH; Jensen, PB; Nitiss, JL; Roerth, M; Rose, A; Sehested, M; Wessel, I | 1 |
Boland, MP; Fitzgerald, KA; O'Neill, LA | 1 |
Berger, NA; Chatterjee, S; Gosky, D; Hirota, H | 1 |
Eastmond, DA; Wang, L | 1 |
Snyder, RD | 1 |
9 other study(ies) available for razoxane and merbarone
Article | Year |
---|---|
Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells.
Topics: Alkenes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Humans; Leukemia; Polyenes; Pyrones; Razoxane; Thiobarbiturates | 1996 |
Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells.
Topics: Aclarubicin; Alkenes; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Cycle Proteins; Cell Line; Chromosomes; Cricetinae; DNA-Binding Proteins; Enzyme Inhibitors; Etoposide; G2 Phase; Guanine Nucleotide Exchange Factors; Kidney; Mitosis; Nuclear Proteins; Okadaic Acid; Phosphoprotein Phosphatases; Polyenes; Pyrones; Razoxane; Temperature; Thiobarbiturates; Topoisomerase II Inhibitors | 1996 |
Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II.
Topics: Aclarubicin; Animals; CHO Cells; Cricetinae; DNA Topoisomerases, Type II; Drug Resistance; Ethylenediamines; Etoposide; Glycine; Mutation; Razoxane; Thiobarbiturates; Topoisomerase II Inhibitors; Verapamil | 1997 |
DNA damage signals induction of fas ligand in tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; CHO Cells; Cricetinae; DNA; DNA Damage; Doxorubicin; Enzyme Inhibitors; Etoposide; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Jurkat Cells; Membrane Glycoproteins; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Razoxane; Recombinant Fusion Proteins; Signal Transduction; Teniposide; Thiobarbiturates; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Up-Regulation | 1999 |
Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Amino Acid Substitution; Amsacrine; Animals; Antineoplastic Agents; Binding Sites; Carcinoma, Small Cell; Catalysis; CHO Cells; Consensus Sequence; Cricetinae; Cricetulus; DNA Damage; DNA Mutational Analysis; DNA Topoisomerases, Type II; DNA, Neoplasm; DNA, Single-Stranded; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Lung Neoplasms; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Protein Isoforms; Razoxane; Recombinant Fusion Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Thiobarbiturates; Topoisomerase II Inhibitors; Tumor Stem Cell Assay | 1999 |
Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspases; Cell Line; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; HL-60 Cells; Humans; Isoenzymes; Mitoxantrone; NF-kappa B; Protein Isoforms; Razoxane; Thiobarbiturates; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2000 |
Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Blotting, Western; Cell Survival; CHO Cells; Chromosomes; Cricetinae; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Humans; Melphalan; Mutation; Razoxane; Sister Chromatid Exchange; Thiobarbiturates; Time Factors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2002 |
Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Kinetochores; Mice; Micronucleus Tests; Razoxane; Thiobarbiturates; Topoisomerase II Inhibitors | 2002 |
Evidence from studies with intact mammalian cells that merbarone and bis(dioxopiperazine)s are topoisomerase II poisons.
Topics: Animals; Cell Line; Cricetinae; Cricetulus; DNA Damage; Micronucleus Tests; Molecular Structure; Mutagens; Razoxane; Structure-Activity Relationship; Thiobarbiturates; Topoisomerase II Inhibitors | 2003 |